CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/ CRISPR-associated protein 9)-based gene editing system has aroused great interest in many research fields. However, the efficient and safe delivery of this gene editing system into the target tissues and cells remain a major challenge.During the past decades, nucleic acid nanostructures have been widely developed for drug delivery. In this perspective, we will introduce and discuss the recent progress in the design of multifunctional nucleic acid nanostructures, including RCA-derived DNA, branched DNA, and hybrid DNA, for delivery of the CRISPR/Cas9-based gene editing system. Furthermore, we prospect the challenges and future opportunities of nucleic acid nanotechnology in the delivery of gene editing systems.
K E Y W O R D SCRISPR/Cas9, drug delivery, gene editing, gene therapy, nucleic acid nanostructure 1 | INTRODUCTION CRISPR/Cas9 system is an adaptive immune system of bacteria and archaea, which plays a significant role in preventing foreign nucleic acids. 1,2 When foreign viral or plasmid DNA enters the cell, the specialized Cas proteins snip the foreign DNA into small pieces and paste them into contiguous stretches of DNA, called the CRISPR array. Then, CRISPR RNAs (crRNAs) encoded by the CRISPR array are obtained and maturated with the assistance of trans-activating crRNA (tracrRNA), ribonuclease III, and Cas9. The tracrRNA is hybridized with crRNA to form a two-RNA structure as guide RNA (gRNA), which directs the Cas9 to foreign DNA based on sequence specificity. Finally, the gRNA/Cas9 complex is responsible for the cleavage of target DNA to achieve DNA double-strand breaks (DSBs) to interfere with foreign invaders. 3,4 Inspired by the CRISPR/Cas9 system in bacteria,This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.